Table 3.
Top 10 highly expressed novel (not previously reported, see Materials and Methods for details) miRNAs identified in this study and their corresponding expression levels in four different treatments. Numbers represent average reads per million of three replicates.
| miRNA Name | Sequence (5’ to 3’) | IL | HL | IP | HP |
|---|---|---|---|---|---|
| tae-miR143 | TGAAGAGCGCGGGCAGCACAA | 265.7 | 263.9 | 192.4 | 307.1 |
| tae-miR92 | GGGCTATTAGCTCAGTGGTA | 136.9 | 185.9 | 116.5 | 192.4 |
| tae-miR117 | TCCGAGTGGCGGCACCA | 135.8 | 163.8 | 150.2 | 153.3 |
| tae-miR132 | TCCTACTTGGGGAGCCA | 130.6 | 128.6 | 200.5 | 212.9 |
| tae-miR95 | GTCCCAGCGTGGTCGCCA | 122.8 | 112.2 | 131.0 | 128.6 |
| tae-miR34 | AGCCAACAACCTCCTAGTTCC | 119.8 | 80.9 | 77.0 | 124.1 |
| tae-miR36 | AGCGGAGTAGAGCAGT | 110.2 | 225.4 | 149.6 | 167.1 |
| tae-miR102 | TCACAAATATAAGATGTTCTG | 102.3 | 115.0 | 116.2 | 120.4 |
| tae-miR107 | TCATGGCAGCAACCGGGACTA | 87.4 | 83.6 | 0.0 | 0.0 |
| tae-miR133 | TCCTGCCGACCACGCCA | 80.7 | 77.3 | 78.6 | 77.5 |
IL, Infected Louise; HL, Healthy Louise; IP, Infected Penawawa; HP, Healthy Penawawa.